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Abstract 
Patulin has been shown to have diabetogenic effects in mice. The effects on pancreatic β-cell 
viability and function of secondary metabolite patulin were investigated. Using forty adult albino 
male rats which divided into 4 groups. Control group was injected subcutaneously daily with 
distilled water for one week; group I was injected subcutaneously daily with Patulin (0.2 
mg/kg/day) for two weeks. Group II was injected with the same toxin and dose for two weeks 
after that they were treated by Goji extract (2 ml/kg /day.) for two weeks. Group III was treated 
by Goji for two weeks after that they were injected with patulin for two weeks. Some biochemical 
parameters of blood samples for experimental rodents were evaluated. Patulin group shows 
significant increase in amylase and glucose levels. But level of C-peptide and Insulin decreased 
significantly in this group. However, there is no significant alteration in Lipase level between 
patulin group and control. Groups treated with goji extract in groups two and three (therapeutic 
and prophylactic) illustrated non significant alteration in biochemical parameters compared to 
control. 
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1. Introduction 
Mycotoxins are reported to be important for infection and possibly growth under natural environmental 
conditions. A known example of mycotoxins is patulin [1]. Patulin has been used as a model for exposure to 
secondary metabolites via contaminated food; it is produced by fungi, in particular Penicillium and Aspergillus, 
which may contaminate food products like apples and apple juice. The effects of patulin have been studied 
extensively, where it has been shown to be both genotoxic and neurotoxic through its covalent binding to essential 
sulphydryl groups in proteins and peptides. This toxicity of patulin has already been demonstrated against various 
mammalian cells and has been attributed to its ability to inhibit RNA and protein synthesis. It is also interfere with 
the activity of many enzymes such as glycogen phosphorylase, glucose- 6-phosphatase, hexokinase and aldolase 
that are considered crucial for cell survival [2]. 
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Fig-1. Chemical structure of patulin(PAT) [Ref ] 
 
Lycium barbarum fruit, generally called goji berry or wolfberry, is a well-known traditional Chinese medicine. 
Goji berry has shown a wide range of health benefits such as the functions and activities associated with the liver, 
kidney, eyesight, sex, immune system, and longevity [3]. Also, it improves the insulin resistance of the cells and 
prevents damage from diabetes [4]. In addition, Lycium barbarum may help in lowering glucose level in diabetic 
person. In vitro hypoglycaemic effect assay indicated that LBP may decrease high glucose level by protecting 
pancreatic β-cells from oxidative damages and alleviating the insulin resistance in liver cells. Hypoglycaemic 
activity of Lycium barbarum fruit may be correlative with polysaccharides, a mainly functional composition, 
considered as potential candidate for developing a new beneficial food or new anti-diabetic agent [5]. It has long 
been used to treat diabetes mellitus and related hyperlipidemia [6].                     
 
 
Fig-2. LyciumBarbarum (goji berry) [7] 
 
In this study, the biochemical profile of fungal secondary metabolite,  patulin, on the INS-1 rat β-cell was 
examined,  in order to evaluate the possible role of Goji extract in reversing patulin toxicity.  
 
2. Materials and Methods 
2.1. Chemicals 
Patulin (4-hydroxy-4H-furo[3, 2-c]pyran-2 (6H)- one) was obtained from Sigma Chemical Company. 
 
2.2. Extraction of Goji Wine 
Goji berry was extracted according to method described by Yang and Baojun [8]where, 5 g of goji fruits,  25 
mL alcohol and 75 ml distilled water were put into Erlenmeyer flask (the ratio of goji berry and alcohol is referred 
to the ratio of making commercial goji wine). The Erlenmeyer flask was sealed with parafilm and tinfoil and put in 
refrigerator for 5 days. filtration was made to separate the solid and liquid phases after finishing steeping process, 
solvent is removed from filtrate by rotatory evaporator to obtain crude goji extract. 
 
2.3. Animals and Experimental Design 
2.3.1. Animals 
Forty male adult albino rats weighing 240-300 g at the age of 3.0-4.0 months were obtained from the animal 
house, Faculty of Medicine, Assiut University. They were housed in standard environmental conditions (22± 3°C, 
and a 12 h light/ dark cycle as perCPCSEA guidelines) and fed with standard rodent diet. 
The rats were randomly assigned to four groups of 10 rats each (5 rats in each cage) and treated as follows: 
Control group: injected subcutaneously daily with distilled water;  
Group I: injected subcutaneously daily with Patulin (0.2 mg/kg/day) for two weeks respectively.  
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Group II: injected by Patulin as a previous dose for two weeks after that they were treated with goji extract (2 
ml/kg/day) for another two weeks. 
Group III: treated by goji extract for two weeks then, they were injected subcutaneously with the same dose of the 
toxin also for another two weeks.  
 
2.4. Biochemical Studies 
Animals were anesthetized under light diethyl ether and blood samples were collected from the heart into plain 
tubes and stored at -20°C until analyses were performed. Sera were used for the measurement of Amylase, Lipase, 
Glucose, C-peptide and Insulin. Level of Amylase was measured according to Ranson [9] level of Lipase was 
measured according to Rick [10] level of Glucose was measured according to Trinder [11] level of C-peptide was 
measured by ELISA kit that was purchased from IMMUNOSPEC Company and  level of Insulin was measured by 
ELISA kit that was purchased from Demeditec. 
 
2.5. Statistical Analysis 
The data were presented as mean ± SEM and the level of significance between groups were *p<0.05, ** 
p<0.01, *** p<0.0001. They were analysed using one-way ANOVA followed by Newman-keuls test. statistical 
graph pad prism 5 was used for the analysis of the data. 
 
3. Results 
The biochemical changes were studied in blood of male albino rats as a result of administration of a dose from 
Patulin (0.2 mg/kg b. w.) and observed over a period of two weeks (GI) compared to the control group. GII treated 
by Patulin as previous dose for two weeks after that they were injected subcutaneously with goji extract 2 ml /kg 
/day for two weeks. In addition GIII treated by goji for two weeks then, they were injected subcutaneously with 
the same toxin for two weeks. 
Table. 1. and Fig. 3. represent the mean value of Amylase concentration (μkat/l) of G I treated animals for two 
weeks to be (40.46±0.4) which was highly significantly increased from normal value of control group (33.75 ± 
0.32), where p<0.001. On the other hand, Non-significant changes in the mean value of amylase concentrations 
were observed between GII (32.18 ± 0.4) and GIII (30.76 ± 0.8) compared to control.The mean value of Lipase 
concentration (μkat/l) table.1.and Fig.4. of G1 (0.185 ± 0.007), G II and G III showed no significant change 
(P>0.05) compared with control group. Table.1. and Fig.5.represent the mean value of glucose concentration 
(mmol/l) of G I was significantly elevated to (10.82±1.33) (p<0.05)than normal control samples (7.604±0.383). 
This level was still slightly elevated to 8.31±0.77 in GII (p>0.05), and 9.77±0.64 in GIII (p<0.05), but it is still 
within normal range with control group. The mean value of C-peptide concentration (ng/ml) in Table.1. and 
Fig.6.showed significant decrease (P > 0.05) compared with control. However, No significant changes in the mean 
value of C-peptide were observed between GII and GIII compared to control. The mean value of Insulin 
concentration (μlU/ml) in Table.1and Fig.7. showed significant decrease (P > 0.05) compared with control. 
However, This decrease returned again back to normal value in GII and GIII respectively with non-significant 
change compared to control group.  
 
Table-1. Effect of Patulin (0.2 mg/Kg b. w.) and Goji extract (2 ml/kg /day) on Some Biochemical Parameters of Male Rats: 
Groups Control GI GII GIII 
Amylase(μkat/l) 33.75 ± 0.32 40.46 ± 0.4*** 32.18 ± 0.4 N.S 30.76 ± 0.8 N.S 
Lipase(μkat/l) 0.217±0.04 0.189±0.03  N.S 0.207±0.01 N.S 0.241±0.007 N.S 
Glucose(mmol/l) 7.604±0.383 10.82±1.33* 8.31±0.77 N.S 9.77±0.64 N.S 
C-peptide(ng/ml) 0.341±0.02 0.197 ± 0.01* 0.297 ± 0.01 N.S 0.338 ± 0.03 N.S 
Insulin(μl U/m) 0.58±0.101 0.383±0.13* 1.35±0.10*** 1.54±0.13*** 
Values are expressed as the mean ± SE for 10 animals in each group. 
 GI = Treated group with Patulin.  
GII , GIII = Treated groups with Goji 
Significant change in comparison between groups:  
*p<0.05; ***p<0.001 
N.S Non significant (P > 0.05)  
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Fig-3. α-amylase levels in control and treated groups with patulin (2 
mg/kg.B.W) and goji extract (2 ml/kg.B.W) 
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Fig-4. Lipase levels in control and treated groups with patulin (2 
mg/kg.B.W) and goji extract (2 ml/kg.B.W) 
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Fig-5. Glucose levels in control and treated groups with patulin (2 
mg/kg.B.W) and goji extract (2 ml/kg.B.W) 
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Fig-6. C-peptide levels in control and treated groups with patulin (2 
mg/kg.B.W) and goji extract (2 ml/kg.B.W) 
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Fig-7. Insulin levels in control and treated groups with patulin (2 
mg/kg.B.W) and goji extract (2 ml/kg.B.W) 
 
4. Discussion 
The present study is a biochemical analysis on the effect of microbial product, patulin on INS-1 pancreatic beta 
cells (β-cells) and the possible role of goji extract as a therapy on pancreas dysfunction. The destruction of β- cells 
and development of type 1 diabetes have been linked with exposure to environmental factors [12] which may 
contribute up to 50% of the risk of developing this type of diabetes [13]. The most important environmental 
factors are thought to be infection (viral infection), diet (lack of particular food during childhood) and some 
inorganic compounds (arsenate ions) [14, 15]. To study pancreatic function of rats treated with patulin, α-amylase, 
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lipase, glucose, c-peptide and insulin have been measured as biochemical indicators. Alpha-amylase catalyzes the 
hydrolysis of α- [1, 4]-D-glycosidic linkages of starch and other glucose polymers. Inhibitors of this enzyme could 
be of use in the treatment of diabetes, resulting in inhibition of starch breaking and decreases levels of blood 
glucose [16]. Because of the harmful side-effects of synthetic products and the fact that plants are easily accessible, 
interest in drugs of herbal origin has significantly increased.Our present biochemical data in the patulintreated  
rats showed an obvious increasing (p<0.001) in pancreatic levels of amylase as it is shown in Table. 1 and Fig.3.  
These elevation levels attributed to acute pancreatitis caused by patulin [17]. Also, many reports have dealt with 
the relationship between blood amylase and carbohydrate metabolism [18-20]or hormones that affect 
carbohydrate metabolism [20-22].These studies showed that  high levels of amylase result from administration of 
hormones that decreases utilization of carbohydrate or in physiological states of diminished carbohydrate 
utilization. 
Another parameter is lipase, which is triacylglycerol acylhydrolase and an omnipresent enzyme with 
physiological significance and industrial potential. It catalyzes the hydrolysis of triglycerides to glycerol and free 
fatty acids. It is soluble in water and hydrolyzes insoluble substrates to more polar lipolytic products. Lipase is 
released from pancreatic acinar cells and reabsorbed by the kidney tubules So, it remains elevated for prolonged 
period which may be helpful in late presenting cases [23]. In this study, there is non-significant (P>0.05) change 
between patulin treated group and control as it is shown from Table. 1. and Fig.4. Where, Many studies have 
reported a negative predictive value of serum lipase in diagnosing acute pancreatitis to be between 94 -100 % even 
if amylase increases significantly [24, 25]. 
The digestive tract breaks down carbohydrates such as, starch and sugars found in many foods to glucose, a 
form of sugar that enters the bloodstream. With the help of the hormone insulin, cells found in the body absorb 
glucose and use it for energy. When the body doesn't make enough insulin (pancreas dysfunction) leading to 
accumulation of sugar in the blood and diabetes. In our study level of glucose in the blood was measured after 
administration of patulin for two weeks (G I) and it shows highly significant increase (P<0.05) in the mean value in 
Table 1 and Fig 5. This leads to damaging nerves and blood vessels and thus complications such as heart disease, 
stroke, kidney disease, blindness, dental disease, and amputations. Other complications of diabetes may increase 
susceptibility to other diseases and loss of mobility with aging [26]. 
In addition, c-peptide and insulin levels in serum were measured. C-peptide is produced in equal amounts to 
insulin and can therefore be used to assess endogenous insulin secretion in type-1-diabetes. The physiology of C-
peptide makes it appropriate for assessing insulin secretion. Insulin is produced in the pancreatic b-cells by 
enzymatic cleavage of the prohormone precursor proinsulin to produce insulin and C-peptide in equimolar 
amounts. Its half-life is longer than insulin (20–30 vs. 3–5 min) and it therefore circulates at concentrations 
approximately five times higher in the systemic circulation [27, 28]. From Table.1 and Fig.6 it is cleared that 
mean value of c-peptide in rats treated with patulin shows significant decrease (P > 0.05) compared with control. 
This scarce value confirms previous results obtained from amylase and glucose that is patulin induced type 1 
diabetes in male rats after subcutaneous injection for 2 weeks. Because dropped levels of c-peptide means significant 
destruction of β-cells and only 10 % of normal cell mass remains [29]. 
Insulin is known to facilitate the absorption of glucose through the specialized membrane of the insulin 
sensitive cells which invariably results in an increase in blood glucose level due to delayed glucose uptake [30]. 
Data from Table.1 and Fig.7. show that there is significant decrease in the mean value (P > 0.05) compared with 
control. Insulin and glucagon have distinct actions in diabetes where, they show that the impairment of pancreatic 
exocrine functions is due to insulin deficiency and relative glucagon predominance [31]. This reducing of insulin 
caused by patulin in G I affect on pancreatic function resulting in changes in the composition and quality of 
pancreatic juice as well as its decreased production leading to accumulation of glucose in the blood and this agreed 
with the increasing in serum glucose showed in Fig.5. [32]. 
From table 1 we observe that levels of amylase, glucose and c-peptide return to normal values of control in 
group II and group III (treatment with goji extract after and before patulin respectively) and also, observe that 
insulin levels show highly significant increase compared to control. The most effective methods for treatment of 
diabetes are inhibition of digestion and absorption of carbohydrates in small intestine. That is happening in two 
manners, The first is inhibition digestion of carbohydrates with inhibition of alpha amylase and the second is 
inhibition of absorption via sodium/glucose co-transporters [16, 33]. Goji berries contain many nutrients with 
high biological activity, such as polysaccharides, carotenoids, phenylpropanoids and others. The polysaccharide 
complex is the most important and the most abundant group of compounds present in goji fruits where it 
comprises 5-8 % of dried matter of the fruits. Luo, et al. [34] have investigated the relation between 
supplementation with different polysaccharide fractions of goji fruit and the levels of glucose in blood. lowered 
blood glucose levels were recognized as substantial hypoglycemic effects. It was found that all goji preparations 
resulted in significantly decreased blood glucose levels after 10 days of treatment in the tested animals, indicating 
that there was hypoglycemic effect. implying that L. barbarumpolysaccharides were major bioactive components in 
the hypoglycemiceffect. Also, antioxidative protective mechanisms illustrated by Li [35] who said that after goji 
polysaccharide fractions treatment, The antioxidative activity of superoxide dismutase, catalase and glutathione 
was significantly increased. Moreover, free radical scavenging activity was also elevated. 
In conclusion, this study illustrates that patulin is cytotoxic to INS-1 cells, leading to the possibility of this 
compound may contribute to the development of diabetes, the assumption being that this secondary product can be 
transported to the pancreas via the blood from the source of its production. And this study confirmed hypoglycemic 
effect of LBP found in goji berries.  
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